Last November, aviation services and distribution group Dart pleased investors with strong half time numbers to 30 September in some pretty tough markets. Profits, pre-tax and goodwill, spiked up from £7.4m to £11.1m on substantially higher turnover of £140.4m (£119.7m), and shareholders enjoyed a 10% dividend uplift to over 2p a share. During the first half, Dart's capital expenditure was some £23m, mainly pertaining to the purchase of Boeing 737-300 aircraft for its aviation services division. This part of the business, which delivered £89m of first half sales, includes freight forwarder Benair Freight International and Channel Express (Air Services), which operates contract charter passenger and freight air services. Channel Express also runs budget services from the North and Northern Ireland under the trading name Jet2.com. Dart's other division is the distribution one - Fowler Welch-Coolchain. It distributes fresh produce and horticulture products for supermarkets and their suppliers, and despite facing tricky pricing issues, management is optimistic about the division's 'future profitable growth'. Admittedly, Dart is a seasonal play, since the lauded Jet2.com turns in profits over the summer and losses in the weaker winter months. Yet last year to March, pre-tax profits (stripping out goodwill) edged up from £7.9m to £9m. And in an encouraging September update, Dart predicted pre-tax profits for the year to March 2005 would be 'materially' ahead of market expectations. Well worth holding.
Market cap: £129m
PE Forecast: n/a
Share price: 374p
Growth Company Investor is the leading magazine for investors in AIM and boasts award-winning research and analysis coverage.
Subscribe now and receive a 50% discount
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Fast-growing Alliance Pharma is to buy most of Cambridge Laboratories' trade and assets for £14.3m and £16.4m.
Investors seeking to back a business with exceptionally high earnings visibility and a burgeoning order book should look no further than Norwich-based infrastructure services specialist May Gurney.
Staff rostering software specialist Allocate, buoyed by 27% organic growth in the six months to November, aims to speed expansion with several acquisitions in coming years.